BREAKING
Home » Posts Tagged "TP-05"

Lyme disease prevention: Tarsus Pharmaceuticals initiates clinical trial for oral, non-vaccine TP-05

By

By NewsDesk  @infectiousdiseasenews TP-05 is designed to kill infected ticks attached to the human body before they can transmit the Borrelia bacteria that causes Lyme disease Late clinical-stage biopharmaceutical...

Lyme disease investigational drug: FDA accepts IND application

By

By NewsDesk  @infectiousdiseasenews Biopharmaceutical company, Tarsus Pharmaceuticals, recently announced that the U.S. Food and Drug Administration (FDA) has accepted the Company’s Investigational...